Michael W Kattan

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. doi The Wisdom of Crowds of Doctors: Their Average Predictions Outperform Their Individual Ones
    Michael W Kattan
    Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH MWK, COR, cy, KC
    Med Decis Making 36:536-40. 2016
  2. doi Comparison of two ordinal prediction models: A cancer staging system example
    Michael W Kattan
    Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA
    Clin Trials 12:342-7. 2015
  3. pmc A simulation model of colorectal cancer surveillance and recurrence
    Johnie Rose
    Case Western Reserve University School of Medicine, 11000 Cedar Ave, Ste, 402, 44106 7136 Cleveland, OH, USA
    BMC Med Inform Decis Mak 14:29. 2014
  4. pmc The REDUCE metagram: a comprehensive prediction tool for determining the utility of dutasteride chemoprevention in men at risk for prostate cancer
    Carvell T Nguyen
    Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic Foundation Cleveland, OH, USA
    Front Oncol 2:138. 2012
  5. pmc Prediction of morbidity and mortality in patients with type 2 diabetes
    Brian J Wells
    Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, United States
    Peerj 1:e87. 2013
  6. doi Clinicians versus nomogram: predicting future technetium-99m bone scan positivity in patients with rising prostate-specific antigen after radical prostatectomy for prostate cancer
    Michael W Kattan
    Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Urology 81:956-61. 2013
  7. ncbi A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy
    Michael W Kattan
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 101:2509-15. 2004
  8. pmc Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy
    Zohar A Dotan
    Department of Quantitative Health Sciences, The Cleveland Clinic Foundation, 9500 Euclid Avenue Wb 4, Cleveland, OH 44195, USA
    J Clin Oncol 23:1962-8. 2005
  9. ncbi When and how to use informatics tools in caring for urologic patients
    Michael W Kattan
    Department of Quantitative Health Sciences, Cleveland Clinic Foundation, OH 44195, USA
    Nat Clin Pract Urol 2:183-90. 2005
  10. ncbi Evidence for the usefulness of nomograms
    Michael W Kattan
    Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH 44195, USA
    Nat Clin Pract Urol 4:638-9. 2007

Collaborators

Detail Information

Publications118 found, 100 shown here

  1. doi The Wisdom of Crowds of Doctors: Their Average Predictions Outperform Their Individual Ones
    Michael W Kattan
    Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH MWK, COR, cy, KC
    Med Decis Making 36:536-40. 2016
    ..Our goals were therefore to investigate accuracy of the average predictions for groups of clinicians and to compare this accuracy with a published statistical prediction model...
  2. doi Comparison of two ordinal prediction models: A cancer staging system example
    Michael W Kattan
    Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA
    Clin Trials 12:342-7. 2015
    ..Choosing to replace or maintain an existing cancer staging system is a difficult task. The system plays a critical role in patient counselling and treatment decision making because the staging system conveys prognosis...
  3. pmc A simulation model of colorectal cancer surveillance and recurrence
    Johnie Rose
    Case Western Reserve University School of Medicine, 11000 Cedar Ave, Ste, 402, 44106 7136 Cleveland, OH, USA
    BMC Med Inform Decis Mak 14:29. 2014
    ..The model's ability to predict outcomes for a group of patients under a specified surveillance strategy is validated...
  4. pmc The REDUCE metagram: a comprehensive prediction tool for determining the utility of dutasteride chemoprevention in men at risk for prostate cancer
    Carvell T Nguyen
    Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic Foundation Cleveland, OH, USA
    Front Oncol 2:138. 2012
    ....
  5. pmc Prediction of morbidity and mortality in patients with type 2 diabetes
    Brian J Wells
    Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, United States
    Peerj 1:e87. 2013
    ..This may be a valuable tool to aid the clinician's choice of an oral hypoglycemic, to better inform patients, and to motivate dialogue between physician and patient...
  6. doi Clinicians versus nomogram: predicting future technetium-99m bone scan positivity in patients with rising prostate-specific antigen after radical prostatectomy for prostate cancer
    Michael W Kattan
    Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Urology 81:956-61. 2013
    ..To compare the ability of clinicians vs a nomogram at predicting future bone scan positivity in patients with prostate cancer...
  7. ncbi A tool for predicting breast carcinoma mortality in women who do not receive adjuvant therapy
    Michael W Kattan
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 101:2509-15. 2004
    ....
  8. pmc Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy
    Zohar A Dotan
    Department of Quantitative Health Sciences, The Cleveland Clinic Foundation, 9500 Euclid Avenue Wb 4, Cleveland, OH 44195, USA
    J Clin Oncol 23:1962-8. 2005
    ..We studied patient characteristics to build a predictive model for a positive scan...
  9. ncbi When and how to use informatics tools in caring for urologic patients
    Michael W Kattan
    Department of Quantitative Health Sciences, Cleveland Clinic Foundation, OH 44195, USA
    Nat Clin Pract Urol 2:183-90. 2005
    ..Many nomograms have been developed, for all prostate cancer clinical states. Some of these are discussed in this review, as is their utility in facilitating decision making and informed consent...
  10. ncbi Evidence for the usefulness of nomograms
    Michael W Kattan
    Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH 44195, USA
    Nat Clin Pract Urol 4:638-9. 2007
  11. doi The prediction philosophy in statistics
    Michael W Kattan
    Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH 44195, USA
    Urol Oncol 26:316-9. 2008
    ..The reporting of P values is de-emphasized from the prediction philosophy perspective, and incremental predictive accuracy has become the metric of choice. Ties to individual patient decision making and outcomes research are presented...
  12. ncbi Do we need more nomograms for predicting outcomes in patients with prostate cancer?
    Michael W Kattan
    Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, USA
    Nat Clin Pract Urol 5:366-7. 2008
  13. ncbi Should I use this nomogram?
    Michael W Kattan
    Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH 44195, USA
    BJU Int 102:421-2. 2008
  14. doi Evaluating a marker's contribution to a nomogram: the GEMCaP example
    Michael W Kattan
    Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio 44195, USA
    Clin Cancer Res 16:1-3. 2010
    ..This tool predicts well but not perfectly. The Genomic Evaluators of Metastatic Prostate Cancer (GEMCaP) biomarkers hold promise for improving this tool; however, a larger data set that permits more involved analyses is needed...
  15. ncbi The surgical learning curve for prostate cancer control after radical prostatectomy
    Andrew J Vickers
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Natl Cancer Inst 99:1171-7. 2007
    ..We analyzed the surgical learning curve for prostate cancer recurrence after radical prostatectomy...
  16. ncbi Age and PSA predict likelihood of organ-confined disease in men presenting with PSA less than 10 ng/mL: implications for screening
    Michael Aleman
    Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Urology 62:70-4. 2003
    ..5 and 4.0 ng/mL are associated with a 20% detection rate. Furthermore, age has been shown to represent an independent predictor of outcome after radical prostatectomy...
  17. ncbi Prostate volume measured preoperatively predicts for organ-confined disease in men with clinically localized prostate cancer
    Fernando J Bianco
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Urology 69:343-6. 2007
    ....
  18. pmc Effects of pathologic stage on the learning curve for radical prostatectomy: evidence that recurrence in organ-confined cancer is largely related to inadequate surgical technique
    Andrew J Vickers
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Eur Urol 53:960-6. 2008
    ..We previously demonstrated that there is a learning curve for open radical prostatectomy. We sought to determine whether the effects of the learning curve are modified by pathologic stage...
  19. ncbi A preoperative nomogram identifying decreased risk of positive pelvic lymph nodes in patients with prostate cancer
    Ilias Cagiannos
    Department of Urology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Urol 170:1798-803. 2003
    ..We developed a preoperative nomogram for prediction of lymph node metastases in patients with clinically localized prostate cancer...
  20. ncbi Predicting clinical end points: treatment nomograms in prostate cancer
    Christopher J Di Blasio
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Semin Oncol 30:567-86. 2003
    ..There is need for additional models that predict other clinical end points, especially survival adjusted for quality of life...
  21. pmc Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Natl Cancer Inst 98:715-7. 2006
    ..Thus, a new preoperative nomogram provides robust predictions of prostate cancer recurrence up to 10 years after radical prostatectomy...
  22. pmc Nomogram incorporating PSA level to predict cancer-specific survival for men with clinically localized prostate cancer managed without curative intent
    Michael W Kattan
    Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA
    Cancer 112:69-74. 2008
    ..After collecting data on a large cohort of men who received no initial active prostate cancer therapy, the aim was to develop, and to internally validate, a nomogram for prediction of disease-specific survival...
  23. ncbi Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors
    Michael W Kattan
    Department of Urology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Urol 170:1792-7. 2003
    ....
  24. ncbi Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens
    Peter Swindle
    Department of Urology, Memorial Sloan Kettering Cancer Center, Sidney Kimmel Center for Prostate and Urologic Cancer, New York, New York 10021, USA
    J Urol 174:903-7. 2005
    ..We evaluated the prognostic significance of PSMs using multiple methods of analysis accounting for patients who received adjuvant therapy...
  25. pmc Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate cancer
    Michael W Kattan
    Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA
    Cancer 115:1005-10. 2009
    ..The purpose of this study was to develop and internally validate nomograms to predict the probability of recurrence, both preoperatively and postoperatively, with adjustment for standard parameters plus surgeon experience...
  26. ncbi Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy
    Kristen L Zakian
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Radiology 234:804-14. 2005
    ..To determine whether hydrogen 1 magnetic resonance (MR) spectroscopic imaging can be used to predict aggressiveness of prostate cancer...
  27. pmc Body mass index is weakly associated with, and not a helpful predictor of, disease progression in men with clinically localized prostate carcinoma treated with radical prostatectomy
    Kozhaya N Mallah
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 103:2030-4. 2005
    ....
  28. pmc Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Clin Oncol 23:7005-12. 2005
    ..We have updated the nomogram by extending the predictions to 10 years after RP and have enabled the nomogram predictions to be adjusted for the disease-free interval that a patient has maintained after RP...
  29. doi Preoperative anemia and perioperative outcomes in patients who undergo elective spine surgery
    Andreea Seicean
    Department of Epidemiology and Biostatistics, Case Western Reserve University School of Medicine, Cleveland, OH 44195, USA
    Spine (Phila Pa 1976) 38:1331-41. 2013
    ..Analysis of the prospectively collected American College of Surgeons National Surgical Quality Improvement Program database...
  30. ncbi International validation of a preoperative nomogram for prostate cancer recurrence after radical prostatectomy
    Markus Graefen
    Department of Urology, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Clin Oncol 20:3206-12. 2002
    ..We applied this nomogram to patients from seven different institutions spanning three continents...
  31. ncbi Assessment of the enhancement in predictive accuracy provided by systematic biopsy in predicting outcome for clinically localized prostate cancer
    Markus Graefen
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Urol 171:200-3. 2004
    ..We investigated whether the addition of prostate biopsy features may enhance the accuracy of a nomogram predicting recurrence after radical prostatectomy (RP)...
  32. ncbi Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer
    Michael W Kattan
    Department of Urology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 27, New York, NY 10021, USA
    J Clin Oncol 21:4568-71. 2003
    ..The goal of this study was to create and to externally validate a nomogram for predicting the probability that a patient will develop metastasis within 5 years after three-dimensional conformal radiation therapy (CRT)...
  33. ncbi The utility of magnetic resonance imaging and spectroscopy for predicting insignificant prostate cancer: an initial analysis
    Amita Shukla-Dave
    Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    BJU Int 99:786-93. 2007
    ..To design new models that combine clinical variables and biopsy data with magnetic resonance imaging (MRI) and MR spectroscopic imaging (MRSI) data, and assess their value in predicting the probability of insignificant prostate cancer...
  34. doi Inventory of prostate cancer predictive tools
    Shahrokh F Shariat
    Department of Urology, University of Texas Southwestern Medical Centre, Dallas, Texas 75390 9110, USA
    Curr Opin Urol 18:279-96. 2008
    ..We describe the patient populations to which they apply and the outcomes predicted, and record their individual characteristics...
  35. pmc Testosterone as a predictor of pathological stage in clinically localized prostate cancer
    Ginger Isom-Batz
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Urol 173:1935-7. 2005
    ..We explored the relationship between preoperative total testosterone, and pathological stage and progression in patients with clinically localized prostate cancer treated with radical prostatectomy...
  36. pmc Variations among high volume surgeons in the rate of complications after radical prostatectomy: further evidence that technique matters
    Fernando J Bianco
    Departments of Urology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Urol 173:2099-103. 2005
    ..While better outcomes are associated with high volume surgeons, the degree of variation in outcomes among surgeons has not been fully examined...
  37. ncbi Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy
    Thomas Steuber
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Cancer 120:1499-504. 2007
    ..0.715, p=0.039). In this setting, hK2 did not add diagnostic information. Measurements of individual forms of suPAR and PSA isoforms contributed significantly to discrimination of men with PCa from those with no evidence of malignancy...
  38. doi Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapy
    Nelson N Stone
    Mount Sinai School of Medicine, New York, NY, USA
    Int J Radiat Oncol Biol Phys 73:341-6. 2009
    ..To investigate the biochemical control rates and survival for Gleason score 7-10 prostate cancer patients undergoing permanent prostate brachytherapy as a function of the biologic effective dose (BED)...
  39. pmc Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach
    Andrew J Vickers
    Department of Epidemiology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 115:5460-9. 2009
    ....
  40. ncbi Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens
    James A Eastham
    Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 170:2292-5. 2003
    ..We examined variations in the rate of positive surgical margins among surgeons after controlling for the severity of disease and volume of cases per surgeon...
  41. pmc Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum
    Thomas Steuber
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Cancer 118:1234-40. 2006
    ..Measurements of fPSA and hK2 improve on our ability to counsel patients prior to treatment as to their risk of BCR...
  42. ncbi Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer
    Liang Wang
    Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Rm C 278, New York, NY 10021, USA
    AJR Am J Roentgenol 186:743-8. 2006
    ....
  43. pmc Surgeon experience is strongly associated with biochemical recurrence after radical prostatectomy for all preoperative risk categories
    Eric A Klein
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA
    J Urol 179:2212-6; discussion 2216-7. 2008
    ..In the current study we determined whether the effects of the learning curve are modified by patient risk, as defined by preoperative tumor characteristics...
  44. ncbi Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension
    Liang Wang
    Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Radiology 232:133-9. 2004
    ..To assess the incremental value of endorectal magnetic resonance (MR) imaging findings in addition to clinical variables for prediction of extracapsular extension (ECE) in patients with prostate cancer...
  45. ncbi Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    JAMA 291:1325-32. 2004
    ..Salvage radiotherapy may potentially cure patients with disease recurrence after radical prostatectomy, but previous evidence has suggested that it is ineffective in patients at the highest risk of metastatic disease progression...
  46. ncbi Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer
    Christopher J DiBlasio
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Urology 62:9-18. 2003
    ..There is a need for additional nomograms that predict outcomes after salvage therapy, as well other clinical end points, including QOL-adjusted survival...
  47. ncbi Comparison of endorectal magnetic resonance imaging, guided prostate biopsy and digital rectal examination in the preoperative anatomical localization of prostate cancer
    Michael Mullerad
    Departments of Urology and Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Urol 174:2158-63. 2005
    ..We compared the accuracy of endorectal magnetic resonance imaging (erMRI), transrectal ultrasound (TRUS) guided biopsy and digital rectal examination (DRE) for detecting the location of cancer in the prostate gland and seminal vesicles...
  48. ncbi Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition
    Andrew J Stephenson
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 24:3973-8. 2006
    ..Ten definitions of BCR were evaluated to identify the one that best explains metastatic progression...
  49. doi A novel prognostic nomogram is more accurate than conventional staging systems for predicting survival after resection of hepatocellular carcinoma
    Clifford S Cho
    Hepatobiliary Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Am Coll Surg 206:281-91. 2008
    ..Numerous staging systems have been devised for purposes of risk classification; we sought to identify the optimal staging system to predict postoperative survival...
  50. pmc Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era
    Andrew J Stephenson
    Glickman Urological and Kidney Institute and Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA
    J Clin Oncol 27:4300-5. 2009
    ..Models that predict the risk of PCSM are needed for patient counseling and clinical trial design...
  51. pmc Surgery confounds biology: the predictive value of stage-, grade- and prostate-specific antigen for recurrence after radical prostatectomy as a function of surgeon experience
    Andrew J Vickers
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Int J Cancer 128:1697-702. 2011
    ..Although our findings have no direct clinical implications, studies investigating biological variables as predictors of outcome after curative resection of cancer should consider the impact of surgeon-specific factors...
  52. doi Nomogram for selecting thyroid nodules for ultrasound-guided fine-needle aspiration biopsy based on a quantification of risk of malignancy
    Iain J Nixon
    Department of Head and Neck Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Head Neck 35:1022-5. 2013
    ....
  53. pmc Conditional probability of survival nomogram for 1-, 2-, and 3-year survivors after an R0 resection for gastric cancer
    Johan L Dikken
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 20:1623-30. 2013
    ....
  54. doi A predictive nomogram for recurrence of carcinoma of the major salivary glands
    Safina Ali
    Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    JAMA Otolaryngol Head Neck Surg 139:698-705. 2013
    ..This nomogram quantifies the risk of recurrence in patients with carcinoma of the major salivary glands. It may facilitate patient counseling on prognosis and may help guide management and posttreatment surveillance in these patients...
  55. ncbi Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer
    Makoto Ohori
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 171:1844-9; discussion 1849. 2004
    ..We developed a model to predict the side specific probability of extracapsular extension (ECE) in radical prostatectomy (RP) specimens based on the clinical features of the cancer...
  56. ncbi Bladder cancer as a prognostic factor for upper tract transitional cell carcinoma
    Michael Mullerad
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 172:2177-81. 2004
    ..Overall 5-year disease specific survival is in the range of 16.5% to 95% depending on stage. In this study we evaluated predictors associated with disease recurrence and disease specific survival...
  57. doi An empirical approach to model selection through validation for censored survival data
    Ickwon Choi
    Department of Electrical Engineering and Computer Science, Case Western Reserve University, Cleveland, OH 44106, USA
    J Biomed Inform 44:595-606. 2011
    ..These results of the model selection models and the final models are assessed in a systematic scheme through validation for the independent performance...
  58. ncbi Prognostic impact of positive surgical margins in surgically treated prostate cancer: multi-institutional assessment of 5831 patients
    Pierre I Karakiewicz
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Urology 66:1245-50. 2005
    ....
  59. ncbi Radical prostatectomy nomograms in black American men: accuracy and applicability
    Fernando J Bianco
    Department of Urology, Wayne State University, 4160 John R, Suite 1017, Detroit, MI 48201, USA
    J Urol 170:73-6; discussion 76-7. 2003
    ..We tested the accuracy of prognostic nomograms in a population of AAMs with prostate cancer treated with radical prostatectomy...
  60. ncbi A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy
    Kimberly J Van Zee
    Departments of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Ann Surg Oncol 10:1140-51. 2003
    ..Accurate estimates of the likelihood of additional disease in the axilla could assist greatly in decision-making regarding further treatment...
  61. ncbi Effect of papillary and chromophobe cell type on disease-free survival after nephrectomy for renal cell carcinoma
    Stephen D W Beck
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg Oncol 11:71-7. 2004
    ..Using a large renal tumor database, we examined the effect of tumor histology on the pattern of metastasis and patient survival...
  62. ncbi Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging
    Michael Mullerad
    Department of Urology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Radiology 232:140-6. 2004
    ..To determine whether predictive value of endorectal magnetic resonance (MR) imaging findings in detection of prostate cancer extracapsular extension (ECE) is significantly affected by the reader's subspecialty experience...
  63. ncbi The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy
    Hedvig Hricak
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 100:2655-63. 2004
    ..In the current study, the authors determined the incremental value of endorectal magnetic resonance imaging (eMRI) in making this decision...
  64. ncbi Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms
    Liang Wang
    Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Radiology 238:597-603. 2006
    ..To assess retrospectively the incremental value of endorectal coil magnetic resonance (MR) imaging and combined endorectal MR imaging-MR spectroscopic imaging to the staging nomograms for predicting organ-confined prostate cancer (OCPC)...
  65. ncbi Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram
    Liang Wang
    Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Radiology 242:182-8. 2007
    ..To retrospectively determine whether endorectal magnetic resonance (MR) imaging findings contribute incremental value to the Kattan nomogram for predicting seminal vesicle invasion (SVI) in patients with prostate cancer...
  66. pmc Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy
    Andrew J Stephenson
    Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195 0001, USA
    J Clin Oncol 25:2035-41. 2007
    ..We developed a nomogram to predict the probability of cancer control at 6 years after SRT for PSA-defined recurrence...
  67. ncbi Doctor, what are my chances of having a positive sentinel node? A validated nomogram for risk estimation
    José Luiz B Bevilacqua
    Department of Surgery, Memorial Sloan Kettering Cancer Center, MRI 1026, New York, NY 10021, USA
    J Clin Oncol 25:3670-9. 2007
    ..We developed a user-friendly prediction model (nomogram) based on a large data set to assist in predicting the presence of SLN metastasis...
  68. doi Prognostic models and algorithms in renal cell carcinoma
    Brian R Lane
    Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Avenue, A100, Cleveland, OH 44195, USA
    Urol Clin North Am 35:613-25; vii. 2008
    ..These RCC nomograms allow more accurate counseling of patients regarding their likely clinical course and facilitate treatment planning...
  69. pmc The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis
    Kevin M Pantalone
    Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio, USA
    Diabetes Care 33:1224-9. 2010
    ..The purpose of this study was to assess the relationship of individual sulfonylureas and the risk of overall mortality in a large cohort of patients with type 2 diabetes...
  70. ncbi Is year of radical prostatectomy a predictor of outcome in prostate cancer?
    Ilias Cagiannos
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    J Urol 171:692-6. 2004
    ..We examined whether the year in which radical prostatectomy (RP) was performed is a predictor of treatment outcome after controlling for standard prognostic factors...
  71. doi Magnetic resonance imaging in the prediction of biochemical recurrence of prostate cancer after radical prostatectomy
    Michael H Fuchsjäger
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    BJU Int 104:315-20. 2009
    ..To investigate whether magnetic resonance imaging (MRI) findings, when converted into a scoring system, can predict the biochemical recurrence of prostate cancer after radical prostatectomy (RP)...
  72. ncbi A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy
    Brian R Lane
    Glickman Urological Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    J Urol 178:429-34. 2007
    ..We present novel nomograms that predict the likelihood of benign, likely indolent or potentially aggressive pathological findings based only on readily identifiable preoperative factors...
  73. doi Defining the optimal treatment for clinical stage I nonseminomatous germ cell testicular cancer using decision analysis
    Carvell T Nguyen
    Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Ave, Desk Q10, Cleveland OH, 44195 0001, USA
    J Clin Oncol 28:119-25. 2010
    ..Surveillance was the preferred intervention for all except those patients at high risk for relapse...
  74. doi Development and validation of a nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session in the era of extended prostate sampling
    Ayman S Moussa
    Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA
    BJU Int 106:1309-14. 2010
    ....
  75. ncbi Cancer control with radical prostatectomy alone in 1,000 consecutive patients
    Gerald W Hull
    Department of Urology, Medical University of South Carolina, Charleston, USA
    J Urol 167:528-34. 2002
    ..We analyzed the long-term progression-free probability after radical retropubic prostatectomy in a consecutive series of patients with localized prostate cancer...
  76. ncbi Markers and meaning of primary treatment failure
    Peter W Swindle
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancer, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Urol Clin North Am 30:377-401. 2003
    ..Similarly, patients with a low risk of progression could be placed into observation protocols, potentially sparing them from exhaustive and inappropriate investigations...
  77. ncbi Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma
    Michael W Kattan
    Department of Urology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, C1275 New York, NY 10021, USA
    J Clin Oncol 21:3647-50. 2003
    ..We developed and internally validated a nomogram that combines these factors to predict the probability of 5-year gastric cancer-specific survival on the basis of 1,039 patients treated at a single institution...
  78. ncbi Prediction of progression: nomograms of clinical utility
    Michael W Kattan
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Clin Prostate Cancer 1:90-6. 2002
    ..Such an individualized approach should add value in medical decision making whenever an accurate prediction of the outcome may guide treatment selection...
  79. ncbi Nomograms for prostate cancer
    Andrew J Stephenson
    Section of Urologic Oncology, Glickman Urological Institute, Lerner College of Medicine, Cleveland, OH, USA
    BJU Int 98:39-46. 2006
  80. doi An updated catalog of prostate cancer predictive tools
    Shahrokh F Shariat
    Department of Urology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA
    Cancer 113:3075-99. 2008
    ..Nevertheless, many more predictive tools, comparisons between them, and improvements to existing tools are needed...
  81. doi Use of nomograms for personalized decision-analytic recommendations
    Alex Z Fu
    Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Med Decis Making 30:267-74. 2010
    ....
  82. ncbi Clinical stage T1c prostate cancer: pathologic outcomes following radical prostatectomy in black and white men
    James A Eastham
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Prostate 50:236-40. 2002
    ....
  83. ncbi Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration
    Oren Smaletz
    Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 20:3972-82. 2002
    ..To develop a pretreatment prognostic model for survival of patients with progressive metastatic prostate cancer after castration using parameters that are measured during routine clinical management...
  84. ncbi Validation of the Kattan preoperative nomogram for prostate cancer recurrence using a community based cohort: results from cancer of the prostate strategic urological research endeavor (capsure)
    Kirsten L Greene
    Department of Urology, Program in Urologic Oncology, Urologic Outcomes Research Group, University of California San Francisco 94115 1711, USA
    J Urol 171:2255-9. 2004
    ..We assessed the performance of the Kattan nomogram using the Cancer of the Prostate Strategic Urological Research Endeavor database, a national, largely community based observational disease registry...
  85. pmc Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas
    Murray F Brennan
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Ann Surg 240:293-8. 2004
    ..Predictive nomograms are becoming increasingly used to define and predict outcome. They can be developed at presentation or following treatment and include variables not conventionally used in standard staging systems...
  86. ncbi Preference assessment method affects decision-analytic recommendations: a prostate cancer treatment example
    Elena B Elkin
    Department of Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Med Decis Making 24:504-10. 2004
    ..To evaluate the effect of preference assessment method on treatment recommended by an individualized decision-analytic model for early prostate cancer...
  87. ncbi Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome
    Andrew J Stephenson
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 23:2781-8. 2005
    ..Since 1999, our criteria have excluded patients with persistent postorchiectomy elevation of serum tumor markers (STM) or clinical stage (CS) IIB disease from RPLND...
  88. pmc Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival
    Cristina R Ferrone
    Memorial Sloan Kettering Cancer Center, Department of Surgery, 1275 York Ave, Box 435, New York, NY 10021, USA
    J Clin Oncol 23:7529-35. 2005
    ..A single US institution database was used to test the validity of the pancreatic adenocarcinoma nomogram established at Memorial Sloan-Kettering Cancer Center...
  89. ncbi Analysis of clinical stage T2 prostate cancer: do current subclassifications represent an improvement?
    Ilias Cagiannos
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY 11021, USA
    J Clin Oncol 20:2025-30. 2002
    ..The purpose of this study was to determine whether the extent of palpable cancer within the prostate predicts outcome after radical prostatectomy...
  90. ncbi Comparisons of nomograms and urologists' predictions in prostate cancer
    Phillip L Ross
    Department of Urology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Semin Urol Oncol 20:82-8. 2002
    ..4%, P =.75, 95% confidence interval [CI]: -10.9% to 8.2%). Our data suggest that nomograms do not seem to diminish predictive accuracy and they may be of significant benefit in certain clinical decision making settings...
  91. ncbi Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factor
    Ofer Yossepowitch
    Department of Urology and Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    J Urol 168:2011-5. 2002
    ..We studied our cohort of patients with stage pT4 disease and bladder neck invasion to clarify the true clinical behavior and prognostic significance of bladder neck invasion in radical prostatectomy specimens...
  92. ncbi Race is not a predictor of prostate cancer detection on repeat prostate biopsy
    Brett S Carver
    Department of Urology, Louisiana State University Health Sciences Center and Overton Brooks Veterans Administration Medical Center, Shreveport, Louisiana, USA
    J Urol 172:1853-5. 2004
    ..We evaluated men undergoing repeat prostate biopsies for persistently increased serum prostate specific antigen (PSA) levels to determine if race was a predictor of cancer detection...
  93. ncbi Achieving optimal outcomes after radical prostatectomy
    Jeffery W Saranchuk
    Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    J Clin Oncol 23:4146-51. 2005
    ..We sought to determine the frequency of optimal outcomes after radical prostatectomy and the time to such outcomes...
  94. ncbi Predicting outcomes in renal cell carcinoma
    Brian R Lane
    Glickman Urological Institute, The Cleveland Clinic Foundation, OH 44195, USA
    Curr Opin Urol 15:289-97. 2005
    ..Current therapeutic options for disseminated disease benefit only a small percentage of patients...
  95. pmc Improved prediction of prostate cancer recurrence through systems pathology
    Carlos Cordon-Cardo
    Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Clin Invest 117:1876-83. 2007
    ..This robust platform has broad applications in patient diagnosis, treatment management, and prognostication...
  96. doi Individualized prediction of colon cancer recurrence using a nomogram
    Martin R Weiser
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    J Clin Oncol 26:380-5. 2008
    ..Although easy to implement, there remains significant heterogeneity within each stage grouping. In the era of multimodality treatment, a more refined tool is needed to predict recurrence...
  97. doi A nomogram for predicting disease-specific survival after hepatic resection for metastatic colorectal cancer
    Michael W Kattan
    Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio, USA
    Ann Surg 247:282-7. 2008
    ..By using a nomogram we are trying to improve on the current practice of using prognostic scores for evaluating risks of therapeutic failure...
  98. ncbi Association of preoperative plasma levels of insulin-like growth factor I and insulin-like growth factor binding proteins-2 and -3 with prostate cancer invasion, progression, and metastasis
    Shahrokh F Shariat
    Baylor Prostate Center and Male Reproductive Medicine and Surgery, Baylor College of Medicine and The Methodist Hospital, Houston, TX 77030, USA
    J Clin Oncol 20:833-41. 2002
    ..We tested the hypothesis that preoperative plasma levels of insulin-like growth factor (IGF) binding protein (BP)-2 or IGFBP-3 would predict cancer stage and prognosis in patients undergoing radical prostatectomy...
  99. ncbi Percent free prostate specific antigen is not an independent predictor of organ confinement or prostate specific antigen recurrence in unscreened patients with localized prostate cancer treated with radical prostatectomy
    Markus Graefen
    Department of Urology, University Hospital Hamburg Eppendorf, Germany
    J Urol 167:1306-9. 2002
    ..We studied the controversial relationship of percent free prostate specific antigen (PSA) with organ confined prostate cancer and PSA failure after radical prostatectomy...
  100. ncbi A comprehensive and novel predictive modeling technique using detailed pathology factors in men with localized prostate carcinoma
    Louis Potters
    Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center at Mercy Medical Center, Rockville Centre, New York 11570, USA
    Cancer 95:1451-6. 2002
    ....
  101. ncbi Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy
    Shahrokh F Shariat
    Matsunaga Conte Prostate Cancer Research Center, Scott Department of Urology, Baylor College of Medicine and The Methodist Hospital, Houston, Texas 77030, USA
    Cancer Res 62:5974-9. 2002
    ..In contrast, preoperative RT-PCR-hK2-L status is associated with established markers of aggressive prostate cancer...